AVZO-103
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVZO-103, covering 2026-04-16 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001) [Phase 1, Phase 2]